한빛사논문
- 조회685
Suyeong Seo, Seung-Yeol Nah, Kangwon Lee,* Nakwon Choi,* and Hong Nam Kim*
S. Seo, N. Choi, H. N. Kim
Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea
S. Seo
Program in Nano Science and Technology, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea
S.-Y. Nah
Department of Physiology, College of Veterinary Medicine, Konkuk University, Seoul 05029, Republic of Korea
K. Lee
Department of Applied Bioengineering, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea
N. Choi, H. N. Kim
Division of Bio-Medical Science & Technology, KIST School, Korea University of Science and Technology (UST), Seoul 02792, Republic of Korea
N. Choi
KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul 02841, Republic of Korea
*To whom correspondence should be addressed.
Abstract
Physiologically, brain tumors interact with surrounding vascular and glial cells, and change their responses to survive in brain tissue-specific microenvironments. A major difficulty in brain tumor treatment is caused by the organism's high resistance to pharmaceutical drugs and poor blood–brain barrier (BBB) penetration. Therefore, mimicking the physiological environment of brain tumors on in vitro platforms can aid in predicting the cellular response to drugs. Here, an engineered 3D human glioblastoma in vitro platform that is integrated with a tricultured BBB is presented. First, the barrier function of the constructed BBB model and its reversibility are characterized, after administrating BBB-opening agents through the microvasculature. The brain tumor cells that are cocultured in the BBB show a more aggressive growth pattern and high drug resistance, as well as secreting high concentrations of inflammatory cytokines. Finally, the delivery of BBB-nonpenetrating drugs are promoted by chemically opening the BBB. The results of this study indicate that the platform can potentially study the physiology of the BBB, and monitor drug responses based on the interaction of the brain tumor and BBB.
Keywords : blood-brain barrier, blood-brain barrier-opening, drug delivery, in vitro model, tumor microenvironment
논문정보
- Research article
- 2021년 11월 (BRIC 등록일 2021-11-09)
- 국내 연구진
- 바이오·의료융합 > 바이오센싱 및 나노바이오물질
댓글 작성 로그인
팝업 닫기관련 링크
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
